166 related articles for article (PubMed ID: 32493679)
1. Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?
Sato T; Kusumoto J; Takeda D; Kishimoto M; Kashin M; Furudoi S; Akashi M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):175-180. PubMed ID: 32493679
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
McGowan K; Ivanovski S; Acton C
Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
[TBL] [Abstract][Full Text] [Related]
4. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
5. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
[TBL] [Abstract][Full Text] [Related]
6. Patients' quality of life improves after surgical intervention of stage III medication-related osteonecrosis of the jaw.
Moll S; Mueller S; Meier JK; Reichert TE; Ettl T; Klingelhöffer C
Oral Maxillofac Surg; 2021 Sep; 25(3):359-366. PubMed ID: 33226530
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw.
de Cassia Tornier S; Macedo FJ; Sassi LM; Schussel JL
Support Care Cancer; 2021 Nov; 29(11):6713-6719. PubMed ID: 33973080
[TBL] [Abstract][Full Text] [Related]
8. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
Grisar K; Schol M; Schoenaers J; Dormaar T; Coropciuc R; Vander Poorten V; Politis C
Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
[TBL] [Abstract][Full Text] [Related]
9. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
10. Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.
Van Camp N; Verhelst PJ; Nicot R; Ferri J; Politis C
J Oral Maxillofac Surg; 2021 Sep; 79(9):1892-1901. PubMed ID: 34097863
[TBL] [Abstract][Full Text] [Related]
11. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw and dental extractions: A single-center experience.
Sandhu S; Salous MH; Sankar V; Margalit DN; Villa A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):515-521. PubMed ID: 32723683
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of the clinimetric properties of the Medication-Related Osteonecrosis of the Jaw Quality of Life Questionnaire (MRONJ-QoL).
El-Rabbany M; Blanas N; Sutherland S; Shah PS; Lam DK; Azarpazhooh A
Int J Oral Maxillofac Surg; 2022 Jun; 51(6):768-775. PubMed ID: 34924268
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible.
Doub JB; Kang A; Lee C; Dyalram D; Shih P; Twaddell WS; Lubek JE
J Oral Maxillofac Surg; 2024 Mar; 82(3):332-340. PubMed ID: 38199239
[TBL] [Abstract][Full Text] [Related]
15. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
[TBL] [Abstract][Full Text] [Related]
16. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
Kün-Darbois JD; Fauvel F
Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
[TBL] [Abstract][Full Text] [Related]
17. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
18. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
Yfanti Z; Tetradis S; Nikitakis NG; Alexiou KE; Makris N; Angelopoulos C; Tsiklakis K
Eur J Radiol; 2023 Aug; 165():110916. PubMed ID: 37300936
[TBL] [Abstract][Full Text] [Related]
19. Are Bacteria Just Bystanders in the Pathogenesis of Inflammatory Jaw Conditions?
He P; Francois K; Missaghian N; Le AD; Flynn TR; Shanti RM
J Oral Maxillofac Surg; 2022 Jun; 80(6):1094-1102. PubMed ID: 35405094
[TBL] [Abstract][Full Text] [Related]
20. Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents.
Zadik Y; Ganor Y; Rimon O; Bersudski E; Meirovitz A
Radiother Oncol; 2021 Mar; 156():275-280. PubMed ID: 33373641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
